Most cited papers in Parathyroid Disorders and Treatments
What are the most cited papers in Parathyroid Disorders and Treatments?
The most cited paper in Parathyroid Disorders and Treatments is "Mutation of the mouse klotho gene leads to a syndrome resembling ageing." (M Kuro-o, Y Matsumura, H Aizawa et al., 1997), with 66,570 citations. Next come "Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study" (29,690) and "Revised Equations for Estimated GFR From Serum Creatinine in Japan" (6,534).
Showing 50 of 99 papers. Every paper with more than 924 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Mutation of the mouse klotho gene leads to a syndrome resembling ageing. M Kuro-o, Y Matsumura, H Aizawa et al. · PubMed | 6 Nov 1997 | 66,570 |
| 2 | Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study Ömer Toprak, Hüseyin Kurt, Yasin Sarı et al. · Kidney & Blood Pressure Research | 2017 | 29,690 |
| 3 | Revised Equations for Estimated GFR From Serum Creatinine in Japan Seiichi Matsuo, Enyu Imai, Masaru Horio et al. · American Journal of Kidney Diseases | 2 Apr 2009 | 6,534 |
| 4 | Regulation of the Voltage Gated K+ Channel Kv1.3 by Recombinant Human Klotho Protein Ahmad Almilaji, Sabina Honisch, Guilai Liu et al. · Kidney & Blood Pressure Research | 2014 | 5,609 |
| 5 | The story of phosphorus: Global food security and food for thought Dana Cordell, Jan-Olof Drangert, Stuart B. White · Global Environmental Change | 17 Feb 2009 | 5,213 |
| 6 | Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis Robert M. Neer, Claude D. Arnaud, José Zanchetta et al. · New England Journal of Medicine | 10 May 2001 | 4,604 |
| 7 | Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures Dennis M. Black, Steven Ron Cummings, David B. Karpf et al. · The Lancet | Dec 1996 | 3,860 |
| 8 | Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures Deborah Anne Marshall, O. Johnell, Hans Wedel · BMJ | 18 May 1996 | 3,728 |
| 9 | TGF-β: the master regulator of fibrosis Xiao‐Ming Meng, David J. Nikolic‐Paterson, Hui Y. Lan · Nature Reviews Nephrology | 25 Apr 2016 | 3,595 |
| 10 | Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups Robert Detrano, Alan D. Guerci, J. Jeffrey Carr et al. · New England Journal of Medicine | 26 Mar 2008 | 3,001 |
| 11 | Vitamin D 3 and Calcium to Prevent Hip Fractures in Elderly Women M C Chapuy, M Arlot, F. Duboeuf et al. · New England Journal of Medicine | 3 Dec 1992 | 2,969 |
| 12 | Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy Matthew J. Maurer et al. · New England Journal of Medicine | 27 Aug 2018 | 2,841 |
| 13 | Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis Geoffrey A. Block, Preston Klassen, J. Michael Lazarus et al. · Journal of the American Society of Nephrology | Aug 2004 | 2,697 |
| 14 | Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid Edward Meigs Brown, Gerardo Gamba, Daniela Mendes dos Reis Riccardi et al. · Nature | Dec 1993 | 2,656 |
| 15 | K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease Shaul G. Massry et al. · University of Groningen research database (University of Groningen / Centre for Information Technology) | Oct 2003 | 2,541 |
| 16 | Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis William G. Goodman, JONATHAN G GOLDIN, Beatriz D. Kuizon et al. · New England Journal of Medicine | 18 May 2000 | 2,525 |
| 17 | Overview of general physiologic features and functions of vitamin D Hector F. DeLuca · American Journal of Clinical Nutrition | Dec 2004 | 2,348 |
| 18 | Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures Results From the Fracture Intervention Trial Steven R. Cummings · JAMA | 23 Dec 1998 | 2,292 |
| 19 | Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein Guangbin Luo, Patricia F. Ducy, Marc D. McKee et al. · Nature | Mar 1997 | 2,125 |
| 20 | FGF23 induces left ventricular hypertrophy Christian Faul et al. · Journal of Clinical Investigation | 10 Oct 2011 | 2,030 |
| 21 | Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Sharon M. Moe, Tilman Bernhard Drüeke, John Alastair Cunningham et al. · Kidney International | 26 Apr 2006 | 1,997 |
| 22 | Modified Glomerular Filtration Rate Estimating Equation for Chinese Patients with Chronic Kidney Disease Yingchun Ma, Li Zuo, Jianghua Chen et al. · Journal of the American Society of Nephrology | 20 Sep 2006 | 1,955 |
| 23 | Suppression of Aging in Mice by the Hormone Klotho Hiroshi Kurosu, Masaya Yamamoto, Jeremy D. Clark et al. · Science | 25 Aug 2005 | 1,954 |
| 24 | Effect of Risedronate on the Risk of Hip Fracture in Elderly Women Michael R. McClung, Piet Geusens, Paul D. Miller et al. · New England Journal of Medicine | Feb 2001 | 1,931 |
| 25 | FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis Takashi Shimada, Hisashi Hasegawa, Y. Yamazaki et al. · Journal of Bone and Mineral Research | Mar 2004 | 1,891 |
| 26 | Klotho converts canonical FGF receptor into a specific receptor for FGF23 Itaru Urakawa, Yuji Yamazaki, Takashi Shimada et al. · Nature | 29 Oct 2006 | 1,855 |
| 27 | Coronary Artery Calcium Score Combined With Framingham Score for Risk Prediction in Asymptomatic Individuals Philip Greenland · JAMA | 13 Jan 2004 | 1,843 |
| 28 | Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis Poul Frølund Vestergaard · Osteoporosis International | 26 Oct 2006 | 1,828 |
| 29 | Amyloid Deposits and Amyloidosis George G. Glenner · New England Journal of Medicine | 5 Jun 1980 | 1,795 |
| 30 | Magnesium in Man: Implications for Health and Disease Jeroen H. F. de Baaij, Joost G.J. Hoenderop, René J.M. Bindels · Physiological Reviews | 24 Dec 2014 | 1,753 |
| 31 | Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis Orlando M. Gutiérrez, Michael Mannstadt, Tamara Isakova et al. · New England Journal of Medicine | 6 Aug 2008 | 1,728 |
| 32 | Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 Kenneth E. White, W. Evans, Jeffery L.H. O'Riordan et al. · Nature Genetics | Nov 2000 | 1,538 |
| 33 | Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop John Paul Bilezikian, Aliya Aziz Khan, John T. Jr. Potts · The Journal of Clinical Endocrinology & Metabolism | Feb 2009 | 1,522 |
| 34 | Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease Adeera Levin, George L. Bakris, Mark E. Molitch et al. · Kidney International | 8 Nov 2006 | 1,522 |
| 35 | Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia Takashi Shimada, SATORU MIZUTANI, Takanori Muto et al. · Proceedings of the National Academy of Sciences | 8 May 2001 | 1,465 |
| 36 | Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients Glenn Matthew Chertow, Steven K. Burke, Paolo Raggi et al. · Kidney International | Jul 2002 | 1,465 |
| 37 | Chronic Kidney Disease Ernesto L. Schiffrin, Mark L. Lipman, Johannes F.E. Mann · Circulation | 2 Jul 2007 | 1,442 |
| 38 | Hypovitaminosis D in Medical Inpatients Melissa K. Thomas, Donald M. Lloyd‐Jones, Ravi Thadhani et al. · New England Journal of Medicine | 19 Mar 1998 | 1,437 |
| 39 | Phosphate Regulation of Vascular Smooth Muscle Cell Calcification Shuichi Jono, Marc D. McKee, Charles E. Murry et al. · Circulation Research | 29 Sep 2000 | 1,428 |
| 40 | The Urea Reduction Ratio and Serum Albumin Concentration as Predictors of Mortality in Patients Undergoing Hemodialysis William Foster Owen, N L Lew, Yi Liu et al. · New England Journal of Medicine | 30 Sep 1993 | 1,426 |
| 41 | Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease Jacques Blacher, Alain P. Guérin, Bruno Pannier et al. · Hypertension | Oct 2001 | 1,420 |
| 42 | Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol Robert P. Heaney, K. Michael Davies, Tai C. Chen et al. · American Journal of Clinical Nutrition | 2003 | 1,413 |
| 43 | Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis Caroline S. Fox, Kunihiro Matsushita, Mark Woodward et al. · The Lancet | 23 Sep 2012 | 1,413 |
| 44 | A fine-structure genetic and chemical study of the enzyme alkaline phosphatase of E. Coli I. Purification and characterization of alkaline phosphatase Alan Garen, Cyrus Levinthal · Biochimica et Biophysica Acta | 1960 | 1,407 |
| 45 | Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism Takashi Shimada, Makoto Kakitani, Y. Yamazaki et al. · Journal of Clinical Investigation | 15 Feb 2004 | 1,377 |
| 46 | Regulation of Fibroblast Growth Factor-23 Signaling by Klotho Hiroshi Kurosu, Yasushi Ogawa, Masayoshi Miyoshi et al. · Journal of Biological Chemistry | 25 Jan 2006 | 1,373 |
| 47 | Long-Term Prognosis Associated With Coronary Calcification Matthew Jay Budoff, Leslee J. Shaw, Sandy T Liu et al. · Journal of the American College of Cardiology | 21 Apr 2007 | 1,349 |
| 48 | The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism Scott M. Wilhelm, Tracy S. Wang, Daniel T. Ruan et al. · JAMA Surgery | 17 Aug 2016 | 1,338 |
| 49 | Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma David H. Henry, Luís Costa, François Goldwasser et al. · Journal of Clinical Oncology | 22 Feb 2011 | 1,274 |
| 50 | Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop John Paul Bilezikian, Maria Luisa Brandi, Richard Eastell et al. · The Journal of Clinical Endocrinology & Metabolism | 27 Aug 2014 | 1,271 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.